Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

67.38
-0.9700-1.42%
Post-market: 67.380.00000.00%16:21 EDT
Volume:1.54M
Turnover:104.51M
Market Cap:5.97B
PE:-24.74
High:69.73
Open:69.35
Low:66.61
Close:68.35
52wk High:80.97
52wk Low:35.80
Shares:88.64M
Float Shares:77.71M
Volume Ratio:1.23
T/O Rate:1.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:5.80
PE(LYR):-32.35

Loading ...

CG Oncology Director Leonard E. Post Disposes of 1,000 Common Shares Worth $72,980

Reuters
·
Sep 18

CG Oncology CEO Joins Cantor Fitzgerald Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

CG Oncology to Present at Upcoming Investor Conferences in September

GlobeNewswire
·
Sep 02

UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 20

CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares

Reuters
·
Aug 19

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Aug 13

CG Oncology Price Target Raised to $85.00/Share from $82.00 by Truist Securities

Dow Jones
·
Aug 07

RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Zentalis Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 07

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 07

TriSalus Life Sciences Q2 Revenue Beats Estimates

Reuters
·
Aug 07

Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 07

CG Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

CG Oncology Publishes Investor Deck Highlighting Cretostimogene Data in High-Risk NMIBC Programs

Reuters
·
Aug 06

CG Oncology Q2 EPS $(0.90) Misses $(0.67) Estimate, Sales $1.157M Beat $360.417K Estimate

Benzinga Earnings
·
Aug 06

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.90 a Share, vs. FactSet Est of $0.66 Loss

MT Newswires Live
·
Aug 06

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 06

CG Oncology Q2 EPS USD -0.9

THOMSON REUTERS
·
Aug 06

CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 06